Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Haoxi Health TechnologyHAO -11.71%21 EV-to-EBIT is 1.61 as of Aug. 19, 2026. GuruFocus rates HAO with a GF Score™ of 21/100. The stock has 5 warning signs investors should review. Among 639 Media - Diversified companies, Haoxi Health Technology ranks better than 91.08% on this metric.
Haoxi Health Technology (NAS:HAO) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Haoxi Health Technology's Enterprise Value for the quarter that ended in Dec. 2025 was $57.80 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Haoxi Health Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-2.35 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haoxi Health Technology EV-to-EBIT Related Terms
Haoxi Health Technology EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Advertising Agencies subindustry, Haoxi Health Technology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haoxi Health Technology EV-to-EBIT vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Haoxi Health Technology's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Haoxi Health Technology's EV-to-EBIT falls into.
Haoxi Health Technology's current Enterprise Value is $-3.77 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Haoxi Health Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-2.35 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haoxi Health Technology (HAO) has a EV-to-EBIT of 1.61 as of Aug. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Haoxi Health Technology and its competitors. According to the industry distribution chart, Haoxi Health Technology ranks #57 out of 639 companies in the Media - Diversified industry, placing it in the top 8.9%.
Is Haoxi Health Technology's EV-to-EBIT too high?
Haoxi Health Technology's current EV-to-EBIT is 1.61. The Media - Diversified industry median EV-to-EBIT is 10.61. Haoxi Health Technology's value of 1.61 is 84.8% below this industry median. Based on the distribution chart, Haoxi Health Technology ranks #57 out of 639 companies in the Media - Diversified industry, which is in the top quartile — a strong position relative to peers. Overall, Haoxi Health Technology has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Haoxi Health Technology's EV-to-EBIT compare to BAOS and DBMM?
According to the Media - Diversified industry distribution chart, Haoxi Health Technology ranks #57 out of 639 companies for EV-to-EBIT. This places Haoxi Health Technology in the top 9% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 10.61. Haoxi Health Technology's value of 1.61 is 84.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Media - Diversified company?
The median EV-to-EBIT among Media - Diversified companies is 10.61, based on 639 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haoxi Health Technology's current EV-to-EBIT of 1.61 is 84.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Haoxi Health Technology and its competitors. For the Media - Diversified industry, the median EV-to-EBIT is 10.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haoxi Health Technology's current EV-to-EBIT is 1.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haoxi Health Technology stock overvalued right now?
Haoxi Health Technology (HAO) has a current EV-to-EBIT of 1.61. The current EV-to-EBIT is 1.61 and 84.8% below the Media - Diversified industry median of 10.61. Haoxi Health Technology's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Haoxi Health Technology (HAO), the current EV-to-EBIT is 1.61 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. The company offers services that include planning, producing, placing, and optimizing online ads especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms. It places advertisements on popular digital platforms such as Toutiao, Douyin, WeChat, and Sina Weibo through media partners. Revenue is generated by providing comprehensive online marketing solutions. The company's operations center on digital advertising via mainstream video and social media channels in the Chinese market.
21GF Score
Get the complete analysis for HAO
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAO has been successfully added to your 
